Zomedica's Business Segments

Zomedica Corp., incorporated in 2013, is an animal health company focused on developing and marketing products for companion animals, including dogs, cats, and horses. The company addresses clinical veterinarians' needs by providing diagnostic and therapeutic medical devices intended to improve patient care and support the economic health of veterinary practices. Zomedica has expanded primarily through acquisitions, enhancing its product portfolio, patent holdings, marketing programs, commercial teams, and distribution channels. It operates through its corporate subsidiary, Zomedica, Inc., which owns four subsidiaries, including Structured Monitoring Products, Inc. and Zomedica Biotechnologies, LLC. The company maintains manufacturing and distribution centers in Roswell, Georgia, and Plymouth, Minnesota, both certified to ISO 13485 standards. Zomedica's product offerings include the TRUFORMA Bulk Acoustic Wave point-of-care diagnostic platform with assays for feline and canine conditions; the VETGuardian PLUS Zero Touch vital signs remote monitoring system; the TRUVIEW digital microscopy platform; and VETIGEL, a fast-acting hemostatic gel licensed from Cresilon, Inc. The company’s revenue grew from zero in 2020 to $32 million in 2025, with ongoing commercialization of six product lines aimed at enhancing veterinary care quality, pet owner satisfaction, and veterinary practice profitability.

The company's reportable segments include Diagnostics, Therapeutic Devices, and Development Services. In the third quarter of 2025, Development Services was added as an additional segment. This addition did not alter the composition, product lines, or prior period amounts of the existing segments.